“Integration of Chronotherapy and Personalized Treatment Approaches”
- One prominent trend in the Global Non-24-Hour Sleep-Wake Disorder Drug Market is the growing focus on personalized chronotherapy, which aligns drug administration with an individual’s biological sleep-wake cycle.
- This approach aims to enhance treatment effectiveness by delivering medications at biologically optimal times, thereby improving sleep regulation and minimizing side effects
- For instance, in 2023, several studies and clinical trials explored circadian-timed melatonin receptor agonists, such as tasimelteon, showing improved outcomes when administered according to individual circadian profiles, paving the way for more precise and targeted therapies.
- These advancements are reshaping sleep disorder management by offering more patient-centric solutions, increasing therapeutic efficacy, and driving innovation in drug development for circadian rhythm disorders
